AstraZeneca Pharma India Limited (BOM:506820)
India
· Delayed Price · Currency is INR 8,672.75
-67.35 (-0.77%)
At close: Mar 9, 2026
AstraZeneca Pharma India Employees
AstraZeneca Pharma India had 802 employees as of March 31, 2025. The number of employees decreased by 138 or -14.68% compared to the previous year.
Employees
802
Change (1Y)
-138
Growth (1Y)
-14.68%
Revenue / Employee
36.29M INR
Profits / Employee
3.35M INR
Market Cap
216.82B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 5,304 |
| Granules India | 4,066 |
| Jubilant Pharmova | 5,547 |
| Caplin Point Laboratories | 3,966 |
| GlaxoSmithKline Pharmaceuticals | 3,113 |
| CORONA Remedies | 4,500 |
| Viyash Scientific | 1,244 |
| Sanofi India | 1,225 |
AstraZeneca Pharma India News
- 25 days ago - ASTRAZEN shares fall over 4% as Q3 EBITDA drops 41.8% YoY to Rs 44.8 crore - Business Upturn
- 27 days ago - Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment - NDTV
- 2 months ago - AstraZeneca Pharma India receives CDSCO approval to import and market Datverzo in India - Business Upturn
- 3 months ago - AstraZeneca Pharma India jumps 3% after teaming up with Sun Pharma to boost access to Hyperkalaemia treatment in India - Business Upturn
- 4 months ago - AstraZeneca and Sun Pharma partner to boost access to Hyperkalaemia treatment in India - Business Upturn
- 5 months ago - AstraZeneca Pharma India to launch hyperkalemia treatment ‘Lokelma’ in November 2025 - Business Upturn
- 5 months ago - AstraZeneca Pharma India secures CDSCO approval for additional indication of Enhertu - Business Upturn
- 6 months ago - AstraZeneca Pharma receives Rs 60.49 crore NPPA show cause notice over Symbicort pricing - Business Upturn